SCHEMBL7987444

SCHEMBL7987444

CCc1nc(=O)c2c(ncn2Cc2cc(C)c(OCc3ccccc3)c(C)c2)[nH]1

nearest known ligand 0.44

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ PARN O95453 1/20 0.42
▸ CNOT7 Q9UIV1 1/20 0.42
▸ SMN1; SMN2 Q16637 4/20 0.39
▸ HPGD P15428 3/20 0.39
▸ HTT P42858 2/20 0.39
▸ ALDH1A1 P00352 2/20 0.39
▸ MEN1 O00255 1/20 0.39
▸ KMT2A Q03164 1/20 0.39
▸ NPC1 O15118 1/20 0.37
▸ P2RX7 Q99572 4/20 0.37
▸ NPSR1 Q6W5P4 1/20 0.36
▸ MAPK14 Q16539 2/20 0.36
▸ SCD O00767 1/20 0.36
▸ TSHR P16473 1/20 0.35
▸ PNP P00491 1/20 0.35
▸ BRD4 O60885 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7992340 0.88 CNOT7 (0.40) PARNCNOT7SMN1; SMN2HPGDHTT
SCHEMBL7975254 0.85 CNOT7 (0.55) PARNCNOT7SMN1; SMN2HPGDALDH1A1
SCHEMBL7987785 0.85 PARN (0.47) PARNCNOT7SMN1; SMN2HPGDALDH1A1
SCHEMBL7987442 0.84 HPGD (0.46) SMN1; SMN2HPGDHTTALDH1A1MEN1
SCHEMBL7987963 0.81 CNOT7 (0.38) PARNCNOT7SMN1; SMN2HPGDALDH1A1
SCHEMBL7984380 0.81 CYP11B1 (0.40) PARNCNOT7SMN1; SMN2HPGDHTT
SCHEMBL7974262 0.80 ALDH1A1 (0.45) PARNCNOT7SMN1; SMN2HPGDHTT
SCHEMBL7973938 0.79 CNOT7 (0.48) PARNCNOT7SMN1; SMN2HPGDALDH1A1
SCHEMBL7985654 0.78 CNOT7 (0.42) PARNCNOT7SMN1; SMN2HPGDALDH1A1
SCHEMBL7985346 0.78 CNOT7 (0.52) PARNCNOT7SMN1; SMN2HPGDALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6310070-B1 FOR TREATING NEPHRITIS, IMPROVING PROTEINURIA DUE TO GLOMERULONEPHRITIS AND PREVENTING AGGRAVATION OF NEPHRITIS JAPAN ENERGY CORPORATION (JP) 2001-10-30 — — US disclosed
EP-0999211-A1 NOVEL PURINE DERIVATIVES AND MEDICINAL USE THEREOF JAPAN ENERGY CORPORATION (JP) 2000-05-10 — — EP disclosed
Send feedback